Chiara Montagna

A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome

Davide Soldini, Chiara Montagna, Peter J. Schüffler et al. · Annals of Oncology · 2012 · 26 citations · Full text

Medicine, Hematology, Oncology +17

Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

Roberto Latagliata, Chiara Montagna, Raffaele Porrini et al. · European Journal Of Haematology · 2015 · 20 citations

Medicine, Hematology, Pharmacology +17

The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma

Simone Brandt, Chiara Montagna, Antoin Georgis et al. · Experimental Hematology and Oncology · 2013 · 18 citations · Full text

Medicine, Oncology, Pathology +17

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib

Roberto Latagliata, Paola Volpicelli, Massimo Breccia et al. · American Journal of Hematology · 2014 · 16 citations · Full text

Medicine, Hematology, Oncology +13

Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response

Roberto Latagliata, Angela Romano, Marco Mancini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 16 citations · Full text

Medicine, Hematology, Oncology +10